HIV Testing After Possible Exposure with Persistent Symptoms
You need HIV antibody testing immediately, followed by repeat testing at 6 weeks, 3 months, and a final test at 6 months post-exposure to definitively rule out HIV infection 1.
Immediate Actions
Test now with both:
- Laboratory-based HIV antigen/antibody (Ag/Ab) combination test
- HIV RNA (nucleic acid test/NAT) if available
The presence of persistent symptoms following a possible HIV exposure is concerning and warrants immediate evaluation, as symptoms may indicate acute retroviral syndrome 1. If you have symptoms compatible with acute HIV infection, perform HIV antibody testing immediately 1.
Testing Timeline Algorithm
Baseline (now):
- HIV Ag/Ab combination test (laboratory-based preferred over rapid test)
- HIV RNA test (particularly important if symptoms suggest acute infection)
- If RNA testing unavailable, the Ag/Ab test alone is acceptable but less sensitive for very early infection 2
6 weeks post-exposure:
- HIV Ag/Ab test
- HIV RNA test
- This catches most infections that would be missed by antibody testing alone 2
3 months post-exposure:
- HIV Ag/Ab test
- Repeat testing at this interval
6 months post-exposure (final):
- HIV Ag/Ab test
- This is the definitive test to rule out infection 1
Critical Context About Your Symptoms
The persistence of symptoms does not necessarily indicate HIV infection, but certain symptoms increase suspicion:
High-risk symptoms for acute HIV (if present within 2-6 weeks of exposure):
- Fever (most strongly associated)
- Rash
- Swollen lymph nodes
- Weight loss
- Vomiting
However, the clinical examination has limited utility for detecting or ruling out early HIV infection 3. The absence of fever or lymphadenopathy only slightly decreases likelihood but does not rule out infection.
Important Caveats
Window period considerations:
- Modern 4th/5th generation Ag/Ab tests detect infection 11-14 days post-exposure 4
- HIV RNA tests can detect infection approximately 10-14 days post-exposure 5
- The 99th percentile window period for Ag/Ab tests is approximately 44 days 5
- However, the 6-month testing timeline remains the standard to definitively exclude infection 1
If you were on or recently stopped long-acting injectable PrEP (cabotegravir):
- You must have both Ag/Ab AND RNA testing at every visit 2
- This is because cabotegravir can suppress viral replication while allowing HIV infection to establish, creating ambiguous test results
Post-Exposure Prophylaxis (PEP) Consideration
If you have NOT yet started PEP and are still within 72 hours of exposure:
- Start PEP immediately with a 3-drug regimen 6, 2
- Preferred regimens: bictegravir/emtricitabine/tenofovir alafenamide OR dolutegravir plus tenofovir (alafenamide or disoproxil fumarate) plus (emtricitabine or lamivudine) 2
- Complete 28 days of treatment 2
If beyond 72 hours:
- PEP is not indicated, but testing remains critical
Precautions During Follow-up Period
Use barrier precautions to prevent potential secondary transmission during the entire 6-month follow-up period 1. This includes condoms for all penetrative sexual acts and not sharing injection equipment.
Seek immediate medical evaluation if you develop:
- Acute illness during follow-up
- New fever, rash, or lymphadenopathy
- Any symptoms suggesting acute retroviral syndrome
The testing schedule is non-negotiable for definitive exclusion of HIV infection, regardless of symptom resolution or persistence.